Stroke, London 2014

Thursday 25 September 2014

With approximately 152,000 strokes occurring in the UK every year, it's important that we can provide top quality care for our patients and help lower the risks.

This essential one day course sees a host of stroke specialists take you through key stages of a stroke patient’s care pathway from identifying risk factors to rehabilitation.

The interactive and peer-reviewed sessions feature plenty of useful take home messages, relevant case studies and topical, engaging discussions. We give you dedicated Q&A time at the end of each session so you can get the answers you need on personal cases, helping you better manage your patients and bring your practice up to date.

Armed with the latest guidelines, new evidence and best practice across key areas of stroke you can demonstrate you are up to date and fit to practice when it comes to your appraisal and revalidation.

This event has already taken place

Course Details

Date: Thursday 25 September 2014

Start Time: 9am

End Time: 5pm

Audience: Physicians, associate specialists, GPs with specialities: Acute medicine, cardiology, stroke medicine, elderly care, any speciality attached to general medicine, intensive care, rehabilitation/neuro-rehabilitation.

Location: BMA House, London, WC1H 9JR

Map of BMA House, London, WC1H 9JR

Course Benefits:

Track Your Learning guides

6 month subscription to BMJ Best Practice

CPD certificate of attendance

Comprehensive digital course handbook

Approved by the Federation of the Royal College of Physicians for 6 category 1 (external) CPD credit(s).
Individual participants should only record the number of hours they attend

Counts towards your Revalidation

BMJ Masterclass in Stroke

8am - 9am Registration and Refreshments
9am - 9.10am Welcome and Introduction by the Chair, Dr Iqbal Malik and Professor Rustam Al-Shahi Salman
9.10am - 9.55am

Making the diagnosis: Identifying TIA and stroke mimics with Professor Anthony Rudd

Our speaker will discuss TIAs and mimics of stroke. This will include:

  • The symptoms and diagnosis of TIAs
  • The delivery of an outpatient neurovascular service
  • Management after a TIA.
9.55am - 10.40am

Making the diagnosis: The right imaging at the right time with Professor Phil White

During this session you will follow clinical cases with our expert speakers who will discuss options for imaging and the outcomes in scenarios where different investigations have been used. These will include:

  • Carotid duplex
  • CT scanning
  • MRI scanning
10.40am - 11.00am Refreshments
11.00am -11.40am

Treatment of acute stroke: thrombolysis and intervention in acute ischaemic stroke with Dr Will Whitely

During this session our speaker will update you on the latest evidence relating to thrombolysis in acute stroke. This will include:

  • An update of the randomised trial evidence on intravenous thrombolysis
  • Applying the evidence in practice: patient selection & complications
  • An update of the randomised trial evidence on reperfusion therapy
  • An update of the randomised trial evidence on hemicraniectomy
11.40am - 12.25pm

Early treatment of stroke: secondary prevention with Professor Catherine Sudlow

During this session our speaker will update you on the latest evidence relating to secondary prevention after acute stroke (pharmacological and endarterectomy).

12.25pm - 1.35pm Lunch
1.35pm - 2.20pm

Sponsored symposium supported by Bristol-Myers Suibb and Pfizer 
 Bristol Myers Squibb and Pfizer

Anti-Coagulation for Stroke Prevention in patients with Non-Valvular Atrial Fibrillation – Are all Oral Direct
Inhibitors the same? 

Dr Amit Mistri - Consultant Physician in Stroke Medicine - University Hospitals of Leicester NHS Trust

This session will provide a clinical overview of the evidence for the oral direct inhibitors for stroke prevention in
patients with non-valvular atrial fibrillation, together with interactive case studies which will discuss
anticoagulation options

This symposium is fully organised and funded by Bristol-Myers Squibb and Pfizer
Job Bag Number: 432UK14PR06872-02
Date of Prep: August 2014

2.20pm - 3.05pm

Special considerations: Haemorrhagic stroke with Professor Rustam Al-Shahi Salman

During this session our speaker will provide advice on how to assess and differentiate between ischaemic and haemorrhagic stroke. He will then focus on the management of intracerebral haemorrhage, particularly looking at:

  • Investigation of cause
  • Stroke unit care
  • Management, including acute BP lowering and surgical options
  • Secondary prevention
3.05pm - 3.25pm Refreshments
3.25pm - 4.10pm

Life after stroke: Complications and rehabilitation with Professor Peter Langhorne

During this session our speaker will discuss your role in the multidisciplinary team in rehabilitation after a stroke. This will include:

  • How to organise your stroke service
  • Prevention of complications, and their management
  • Management of complications
  • Transfer from hospital to home
4.10pm - 4.55pm

Putting it into practice: challenging cases with Dr Iqbal Malik and Dr Arindam Kar

  • How to search for atrial fibrillation, and treat it?
  • Cryptogenic stroke and patent foramen ovale 
  • Medicolegal pitfalls
4.55pm - 5.00pm Summary and closing remarks

 Programme subject to change

Speaker biographies

Dr Iqbal Malik - chair

Consultant Cardiologist and Honorary Senior Lecturer, Imperial College Healthcare NHS Trust, London

Iqbal Malik is a consultant at Imperial College Healthcare NHS Trust, London. He trained at Peterhouse College, Cambridge and then at Guy's and St Thomas’ Hospital, London. After further training in West London, Dr Malik was appointed as a consultant cardiologist at Imperial College Healthcare NHS Trust, London in 2001. At Hammersmith Hospital, he is director of the catheter laboratories and lead for primary angioplasty. He is lead clinician for revascularisation for North West London Cardiac Network and national clinical lead for web transfer systems. His research interests are in stroke prevention (patent foramen ovale closure and carotid stenting), coronary revascularisation and transcatheter aortic valve implantation.

Rustam Al-Shahi Salman - chair

Professor of clinical neurology, MRC senior clinical fellow, & honorary consultant neurologist, University of Edinburgh / NHS Lothian

Rustam Al-Shahi Salman’s interest in neurology began in medical training in Cambridge and after attending advanced neurology and clinical trials courses in Edinburgh. His clinical and research interests encompass all forms of stroke (subarachnoid and intraparenchymal haemorrhage, in particular), intracranial vascular malformations (whether ruptured or not), and—increasingly—incidentalomas detected on brain imaging (whether in clinical practice, in research studies, or as part of so-called ‘health check-ups’). He also runs a rapid access neurology clinic for his local emergency department.

Recent publications:

Poon MTC, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014;85:660-7. 

Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP, for the Scottish Audit of Intracranial Vascular Malformations collaborators. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014;311:1661-9

Langhorne P, Fearon P, Rønning OM, Kaste M, Palomaki H, Vemmos K, Kalra L, Indredavik B, Blomstrand C, Rodgers H, Dennis M, Al-Shahi Salman R, Stroke Unit Trialists’ Collaboration. Stroke unit care benefits patients with intracerebral haemorrhage: systematic review and meta-analysis. Stroke 2013;44(11):3044-9

Declaration of interests: None


Professor Anthony Rudd

National Clinical Director for Stroke, NHS England

Tony Rudd is Professor of Stroke Medicine at Kings College London and a consultant stroke physician at Guy’s and St Thomas’ NHS Foundation Trust. For the last 3 years he has been the London Clinical Director for stroke and since April 2013 the National Clinical Director for Stroke. He is Vice Chairman of the Stroke Association and is the Stroke Programme Director at the Royal College of Physicians, London responsible for the development of the National Clinical Guidelines for stroke and the National Stroke audits. He was awarded a CBE in the Queen’s birthday honours in 2013.

 Recent publications

Bray BD, Ayis S, Campbell J, Cloud GC, James M, Hoffman A, Tyrrell PJ, Wolfe CD, Rudd AG. Associations between Stroke Mortality and Weekend Working by Stroke Specialist Physicians and Registered Nurses: Prospective Multicentre Cohort Study. PLoS Med. 2014 Aug 19;11(8):e1001705. doi: 10.1371/journal.pmed.1001705

Morris S, Hunter RM, Ramsay AI, Boaden R, McKevitt C, Perry C, Pursani N, Rudd AG, Schwamm LH, Turner SJ, Tyrrell PJ, Wolfe CD, Fulop NJ. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. BMJ. 2014 Aug 5;349:g4757. doi: 10.1136/bmj.g4757

Bray BD, Ayis S, Campbell J, Hoffman A, Roughton M, Tyrrell PJ, Wolfe CD, Rudd AG. Associations between the organisation of stroke services, process of care, and mortality in England: prospective cohort study. BMJ. 2013 May 10;346:f2827. doi: 10.1136/bmj.f2827

Professor Phil White

Professor of Interventional and Diagnostic Neurology, Newcastle University

Phil White holds the chair of Neuroradiology at Newcastle University. He is the Co-Principal Investigator of three ongoing randomised trials in stroke amongst a wide portfolio of ongoing research. In 2009 he was appointed chair of Acute Studies Group of the UK Stroke Research Network. He represents Royal College of Radiologists on the Intercolleagiate Stroke Working Party and chairs British Neuroradiologists Standards Committee. He is secretary of the UK Neurointerventional Group, chairs the European Society of Minimally Invasive Neurological Therapy Research Committee and is on the editorial board of the Journal of Neurointerventional Surgery. He is also a specialist advisor to a number of bodies including NICE, Wellcome and HTA.

Decalaration of interests: 

Consultancy work with Microvention, Codman, Covidien for educational purposes
Institutional research funding: Ibex Innovations, Microvention
Travel support in the last three years from Microvention, Codman
Academic interests: National Stroke Strategy, Intercollegiate Stroke working party, Stroke Association, Stroke research Network


Dr William Whiteley

MRC Clinician Scientist & Honorary Consultant Neurologist, University of Edinburgh & NHS Lothian

Will Whiteley is an MRC Clinician Scientist at the University of Edinburgh. His research interests are the targeting of acute treatments for stroke, the development of better methods to predict outcome after stroke, and the use of routinely collected data. As a CSO Clinical Academic Training Fellow, he studied the use of blood biomarkers in stroke, and read for an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine. He is a clinical neurologist for NHS Lothian, actively involved in stroke/TIA clinics, stroke thrombolysis and general neurology.

Recent publications

Jonathan Emberson PhD, Prof Kennedy R Lees MD, Prof Patrick Lyden MD, Lisa Blackwell BSc, Prof Gregory Albers MD, Prof Erich Bluhmki PhD,et al,for the Stroke Thrombolysis Trialists' Collaborative Group  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.The Lancet - 6 August 2014 . DOI: 10.1016/S0140-6736(14)60584-5

William N. Whiteley, PhD; Douglas Thompson, BSc; Gordon Murray, PhD; Geoff Cohen, MA; Richard I. Lindley, FRCP; Joanna Wardlaw, FRCR, FRCP; Peter Sandercock, FRCPE; on behalf of the IST-3 Collaborative Group. Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome.An Analysis of the Third International Stroke Trial. Stroke.2014; 45: 1000-1006.Published online before print March 6, 2014

William N Whiteley, Harold P Adams, Jr, Philip MW Bath,c Eivind Berge, Per Morten Sandset, Martin Dennis, Gordon D Murray, Ka-Sing Lawrence Wong, and Peter AG Sandercock.Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. Jun 2013; 12(6): 539–545.doi: 10.1016/S1474-4422(13)70079-6

Declaration of interests: None

Professor Peter Langhorne

Professor of Stroke care,  University of Glasgow

Peter Langhorne is Professor of Stroke Care at the University of Glasgow, UK. His research work has focussed on the effectiveness of different treatment strategies for stroke patients, including service delivery and stroke rehabilitation. During the last 20 years he has been a coordinator and grant holder for randomised clinical trials of occupational therapy, nursing, physiotherapy and early mobilisation. He also has coordinated systematic reviews and meta-analyses of trials of stroke units, early supported discharge services, outpatient therapy services, intensive physiotherapy input, and stroke liaison worker services. He is the coordinating editor of the Cochrane Stroke Group and has worked within the Cochrane collaboration more broadly to encourage the development of evidence-based practice.

Declaration of interests: None

Dr Arindam Kar

Consultant in Stroke Medicine, HASU Clinical Lead, Imperial College Healthcare NHS trust

Arindam Kar is a consultant stroke physician at Imperial College Healthcare NHS Trust, London. He graduated from Cambridge and Oxford Universities before completing his geriatric and stroke training in north London. He was appointed consultant stroke physician at Imperial in 2009 and is currently the hyper-acute stroke unit clinical lead at Charing Cross Hospital. His interests include improving the delivery of hyper-acute stroke care, atrial fibrillation and stroke subspecialty training.


Further speaker biographies and declarations will be uploaded in due course.